Tiansheng Pharma's IPO

Tiansheng Pharma raised a round of funding on May 19, 2017. Investors include Public.

Tiansheng Pharmaceutical Group (天圣制药) (SHE: 002872) is engaged in pharmaceutical manufacturing and circulation, Chinese herbal medicine planting and processing, drug research and development.…

Articles about Tiansheng Pharma's IPO: